A clinical assessment of mycophenolate drug monitoring after liver transplantation (Q38489448)

3 September 2017

title

A clinical assessment of mycophenolate drug monitoring after liver transplantation (English)

1 reference

3 September 2017

Shin Hwang

1

1 reference

3 September 2017

Sung-Gyu Lee

2

1 reference

3 September 2017

Chul-Soo Ahn

3

1 reference

3 September 2017

Ki-Hun Kim

4

1 reference

3 September 2017

Deok-Bog Moon

5

1 reference

3 September 2017

Tae-Yong Ha

6

1 reference

3 September 2017

Gi-Won Song

7

1 reference

3 September 2017

Dong-Hwan Jung

8

1 reference

3 September 2017

Nam-Kyu Choi

9

1 reference

3 September 2017

Kwan-Woo Kim

10

1 reference

3 September 2017

Young-Dong Yu

11

1 reference

3 September 2017

Gil-Chun Park

12

1 reference

3 September 2017

Pyoung-Jae Park

13

1 reference

3 September 2017

Young-Il Choi

14

1 reference

3 September 2017

publication date

11 January 2010

1 reference

3 September 2017

published in

Clinical Transplantation

1 reference

3 September 2017

volume

24

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

E35-42

1 reference

Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Immunosuppression: towards a logical approach in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Mycophenolate mofetil in liver transplantation--is monotherapy safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Adult-to-adult living donor liver transplantation at the Asan Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Cyclosporin a for treatment of hepatitis C virus after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Management of hepatitis C virus in the transplant patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic acid plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Mycophenolate mofetil monotherapy in liver transplant recipients: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Clinical pharmacokinetics of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2009.01166.X

10.1111/J.1399-0012.2009.01166.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference